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The KDIGO guideline on dialysate
calcium and patient outcomes:
need for hard evidence
To the Editor: It was with great displeasure that we read the
title of a recent article in Kidney International that insinuated
that the Kidney Disease Improving Global Outcomes guide-
line for the chronic kidney disease-associated bone and
mineral disorder (CKD-MBD) will result in an adverse
outcome.1 As correctly noted by the authors, the recommen-
dation concerning dialysate calcium concentration was
graded 2D. It is clearly documented throughout the CKD-
MBD guideline that a level 2D rating indicates ‘we suggest’
and ‘very low’ evidence. This means that different choices will
be appropriate for different patients. Each patient needs help
to arrive at a management decision consistent with his or her
values and preferences. The absence of evidence is a strong
indication for the need of further research.
Clearly, there has been debate about dialysate calcium
concentration that has been published.2,3 Gotch and collea-
gues have furthered their side of the debate by repeated
reports of the same modeling construct, failing to acknowl-
edge the limitations of the assumptions in their model despite
published opposing views on this topic. These potentially
erroneous assumptions include (1) estimating the intestinal
calcium absorption from binders based on data on urine
excretion in healthy individuals, (2) hypothesizing that total
calcium can be used to correctly assess the freely dialyzed
(mostly ionized) calcium concentration, (3) positing that the
prescribed calcium dialysate is accurately delivered, and (4)
claiming that the calcium ﬂux from the rapidly exchangeable
pool of bone will be constant during dialysis. In contrast to
Gotch’s approach of trying to remove a maximum amount of
calcium with dialysis, the Kidney Disease Improving Global
Outcomes work group felt that the unknown risk of acute
alterations in PTH as a result of the acute changes in calcium
was great enough that, in the ‘majority of people’ (but not all),
dialysis should try to be neutral in net calcium ﬂux.4
Thus, we contend that the proposed modeling scheme put
forth by Gotch et al. does not currently add to the evidence
base, and therefore the Kidney Disease Improving Global
Outcomes recommendation that different choices will be
appropriate for different patients remains valid. We also
would have appreciated a more appropriate title, given that
the researchers did not directly test the implementation of the
Kidney Disease Improving Global Outcomes guideline in a
randomized controlled trial.
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The Authors Reply: Drs Moe and Drueke1 claim our analysis
of the Kidney Disease: Improving Global Outcomes (KDIGO)
guidelines was ﬂawed because of ‘limitations in our assump-
tions’, which we wish to address individually.
1. Estimating intestinal calcium (Ca) absorption from urinary
excretion in healthy individuals. No evidence is presented to
support this claimed flaw (we were unable to locate Moe’s
reference no. 4). Our model of net Ca absorption was based
on analysis of intestinal Ca absorption reported in dialysis
patients and healthy subjects over a wide range of serum
calcitriol levels.2 The significance of the 24-h urinary Ca
values is that these data correlated virtually perfectly with
our model derived from an analysis of studies done 20 years
earlier and thus provide strong independent confirmation
of the calcium absorption model.
2. Assuming total Ca can be used to assess the freely dialyzed
ionized Ca. Although transmembrane Ca diffusion is
driven by the local transmembrane ionized Ca concentra-
tion gradient, in fact, the total plasma Ca determines the
amount of total Ca flux, as there is very rapid dissociation
and release of bound Ca in the plasma compartment of
the dialyzer as the ionized concentration falls.3
3. Claiming that Ca flux from the rapidly exchanging pool of
bone will be constant during dialysis. We strenuously object
to this statement, as we have never made such a claim. We
have defined and measured new patient-specific coeffi-
cients to quantify the magnitude of mobilization of Ca
from or deposition in the miscible Ca buffer pool as a
fraction of the total diffusive Ca flux during dialysis.4
The KDIGO work group reported ‘we voted 16 to 1 in
favor of the dialysate Ca recommendation’, but did not cite a
single reference on quantitative modeling of the system,
strongly contradicting the recommendation. Moe’s comment
‘we contend that the modeling scheme put forth by Gotch
et al. does not currently add to the evidence base’ cannot be
justiﬁed without adequately reviewing the body of work.
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